Ali Z Fadhel
Examiner (ID: 9147, Phone: (571)270-0267 , Office: P/1772 )
Most Active Art Unit | 1772 |
Art Unit(s) | 1772 |
Total Applications | 589 |
Issued Applications | 422 |
Pending Applications | 57 |
Abandoned Applications | 110 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18784645
[patent_doc_number] => 20230372234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
[patent_app_type] => utility
[patent_app_number] => 18/351711
[patent_app_country] => US
[patent_app_date] => 2023-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351711
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/351711 | Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles | Jul 12, 2023 | Pending |
Array
(
[id] => 18672930
[patent_doc_number] => 20230310381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/200980
[patent_app_country] => US
[patent_app_date] => 2023-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18200980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/200980 | BENDAMUSTINE PHARMACEUTICAL COMPOSITIONS | May 22, 2023 | Pending |
Array
(
[id] => 18877512
[patent_doc_number] => 20240000881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => TOPICAL TREATMENT FOR ANIMALS
[patent_app_type] => utility
[patent_app_number] => 18/319948
[patent_app_country] => US
[patent_app_date] => 2023-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319948
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319948 | TOPICAL TREATMENT FOR ANIMALS | May 17, 2023 | Pending |
Array
(
[id] => 18550651
[patent_doc_number] => 20230248651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 18/305051
[patent_app_country] => US
[patent_app_date] => 2023-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305051
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305051 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | Apr 20, 2023 | Pending |
Array
(
[id] => 18550764
[patent_doc_number] => 20230248764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => TREATMENT OF BLEPHARITIS
[patent_app_type] => utility
[patent_app_number] => 18/135966
[patent_app_country] => US
[patent_app_date] => 2023-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135966 | TREATMENT OF BLEPHARITIS | Apr 17, 2023 | Pending |
Array
(
[id] => 18815963
[patent_doc_number] => 20230390302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => PHARMACEUTICAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 18/295670
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5986
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295670
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295670 | Pharmaceutical formulation | Apr 3, 2023 | Issued |
Array
(
[id] => 18536202
[patent_doc_number] => 20230241290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => MALLEABLE, CRYOPRESERVED OSTEOGENIC COMPOSITIONS WITH VIABLE CELLS
[patent_app_type] => utility
[patent_app_number] => 18/130484
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130484
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130484 | MALLEABLE, CRYOPRESERVED OSTEOGENIC COMPOSITIONS WITH VIABLE CELLS | Apr 3, 2023 | Pending |
Array
(
[id] => 19011790
[patent_doc_number] => 11918691
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 18/154419
[patent_app_country] => US
[patent_app_date] => 2023-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 64
[patent_no_of_words] => 58467
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18154419
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/154419 | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | Jan 12, 2023 | Issued |
Array
(
[id] => 18509920
[patent_doc_number] => 20230226006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Compositions for the Treatment of Dry Eye and Methods of Use Thereof
[patent_app_type] => utility
[patent_app_number] => 18/082275
[patent_app_country] => US
[patent_app_date] => 2022-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18082275
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/082275 | Compositions for the Treatment of Dry Eye and Methods of Use Thereof | Dec 14, 2022 | Pending |
Array
(
[id] => 18270908
[patent_doc_number] => 20230092150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Self-Neutralizing Amino Acid Based Cationic Compositions
[patent_app_type] => utility
[patent_app_number] => 18/070021
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070021 | Self-Neutralizing Amino Acid Based Cationic Compositions | Nov 27, 2022 | Pending |
Array
(
[id] => 18626547
[patent_doc_number] => 20230285334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/059270
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059270
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059270 | Therapeutic compounds, formulations, and uses thereof | Nov 27, 2022 | Issued |
Array
(
[id] => 19241086
[patent_doc_number] => 12011502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Compositions and methods of administering baclofen
[patent_app_type] => utility
[patent_app_number] => 17/984001
[patent_app_country] => US
[patent_app_date] => 2022-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9717
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984001 | Compositions and methods of administering baclofen | Nov 8, 2022 | Issued |
Array
(
[id] => 18339119
[patent_doc_number] => 20230131068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF TREATING ENDOMETRIAL CANCER USING HEMP EXTRACT
[patent_app_type] => utility
[patent_app_number] => 18/050021
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18050021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/050021 | Methods of treating endometrial cancer using hemp extract | Oct 25, 2022 | Issued |
Array
(
[id] => 18443545
[patent_doc_number] => 11679096
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-20
[patent_title] => Composition and method of treatment of elevated ApoE gene expression related health issues
[patent_app_type] => utility
[patent_app_number] => 17/966916
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10810
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966916
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966916 | Composition and method of treatment of elevated ApoE gene expression related health issues | Oct 16, 2022 | Issued |
Array
(
[id] => 18383367
[patent_doc_number] => 11654131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females
[patent_app_type] => utility
[patent_app_number] => 17/966901
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10640
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966901
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966901 | Composition and method of treatment of health issues related to estrogen metabolism with elevated risk factors in females | Oct 16, 2022 | Issued |
Array
(
[id] => 18307388
[patent_doc_number] => 20230111288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles
[patent_app_type] => utility
[patent_app_number] => 18/046002
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046002
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046002 | Treatment of epithelial cysts by intracystic injection of antineoplastic particles | Oct 11, 2022 | Issued |
Array
(
[id] => 18322222
[patent_doc_number] => 20230120350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
[patent_app_type] => utility
[patent_app_number] => 17/948611
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948611 | MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION | Sep 19, 2022 | Pending |
Array
(
[id] => 19227765
[patent_doc_number] => 12007399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Method of identifying and treating premature infants at risk for BPD
[patent_app_type] => utility
[patent_app_number] => 17/942396
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5625
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942396
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/942396 | Method of identifying and treating premature infants at risk for BPD | Sep 11, 2022 | Issued |
Array
(
[id] => 19195254
[patent_doc_number] => 11992472
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Compositions and methods for enhancing the efficacy of contraceptive microbicides
[patent_app_type] => utility
[patent_app_number] => 17/823020
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4975
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17823020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/823020 | Compositions and methods for enhancing the efficacy of contraceptive microbicides | Aug 28, 2022 | Issued |
Array
(
[id] => 18075763
[patent_doc_number] => 20220401375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => PROTECTING TISSUE AND MITIGATING INJURY FROM RADIATION-INDUCED IONIZING EVENTS
[patent_app_type] => utility
[patent_app_number] => 17/890809
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890809 | PROTECTING TISSUE AND MITIGATING INJURY FROM RADIATION-INDUCED IONIZING EVENTS | Aug 17, 2022 | Pending |